The use of equine chorionic gonadotropin in the treatment of anestrous dairy cows in gonadotropin-releasing hormone/progesterone protocols of 6 or 7 days

被引:27
|
作者
Bryan, M. A. [1 ]
Bo, G. [2 ]
Mapletoft, R. J. [3 ]
Emslie, F. R. [4 ]
机构
[1] VetSouth Ltd, Winton 9718, Southland, New Zealand
[2] IRAC, RA-5145 Cordoba, Argentina
[3] Univ Saskatchewan, Western Coll Vet Med, Saskatoon, SK S7N 5B4, Canada
[4] Bomac Labs Ltd, Auckland 2241, New Zealand
关键词
equine chorionic gonadotropin; anestrus; progesterone; gonadotropin-releasing hormone; TIME ARTIFICIAL-INSEMINATION; REPRODUCTIVE-PERFORMANCE; PREGNANCY RATES; PROGESTERONE; ESTRADIOL; SYNCHRONIZATION; FERTILITY; HORMONE; CATTLE; GNRH;
D O I
10.3168/jds.2012-5452
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
In seasonally calving, pasture-based dairy farm systems, the interval from calving to first estrus is a critical factor affecting reproductive efficiency. This study evaluated the effects of equine chorionic gonadotropin (eCG) on the reproductive response of lactating, seasonally calving dairy cows diagnosed with anovulatory anestrus by rectal palpation. Cows on 15 commercial dairy farms were selected for initial inclusion based on nonobserved estrus by 7 d before the planned start of mating. All cows were palpated rectally and evaluated for body condition score and ovary score, and were included for treatment according to the trial protocol if diagnosed with anovulatory anestrus. All cows received a standard anestrous treatment protocol consisting of insertion of a progesterone device, injection of 100 mu g of GnRH at the time of device insertion, and injection of PGF(2 alpha) at device removal (GPG/P4). Cows were randomly assigned to 1 of 2 groups (6 d or 7 d) for duration of progesterone device insertion. Within each of these groups, cows were further randomly assigned to receive either 400 IU of eCG at device removal or to remain untreated as controls, resulting in a 2 x 2 arrangement of treatment groups: (1) 6-d device and no eCG (n = 484); (2) 6-d device and eCG (n = 462); (3) 7-d device and no eCG (n = 546); and (4) 7-d device and eCG (n = 499). Cows were detected for estrus from the time of progesterone device removal and were inseminated; those not detected in estrus within 60 h after progesterone device removal received 100 mu g of GnRH and were inseminated at 72 h. The primary outcomes considered were proportion of cows conceiving within 7 d of the beginning of breeding (7-d conception rate; 7-d CR), proportion pregnant within 28 d (28-d in calf rate; 28-d ICR), and days to conception (DTC). We found no significant differences between the 6- and 7-d insertion periods and found no 6- or 7-d insertion period x eCG treatment interactions. Inclusion of eCG into either length of GPG/P4 protocol increased 7-d CR (36.0 vs. 30.6%) and 28-d ICR (58.6 vs. 52.3%) and decreased median days to conception. The use of eCG in GPG/P4 breeding protocols will improve reproductive efficiency in seasonally calving, anestrous dairy cattle.
引用
收藏
页码:122 / 131
页数:10
相关论文
共 50 条
  • [21] EFFECTS OF GONADOTROPIN-RELEASING HORMONE AND HUMAN CHORIONIC-GONADOTROPIN ON PREGNANCY RATE IN DAIRY-CATTLE
    LEWIS, GS
    CALDWELL, DW
    REXROAD, CE
    DOWLEN, HH
    OWEN, JR
    JOURNAL OF DAIRY SCIENCE, 1990, 73 (01) : 66 - 72
  • [22] Comparison of gonadotropin-releasing hormone and estradiol benzoate plus gonadotropin-releasing hormone to initiate a progesterone-based timed artificial insemination resynchronization protocol in lactating dairy cows
    Consentini, Carlos E. C.
    Melo, Leonardo F.
    Abadia, Tattiany
    Gonzales, Bruno
    Motta, Jessica C. L.
    Alves, Rodrigo L. O. R.
    Silva, Lucas O. e
    Wiltbank, Milo C.
    Sartori, Roberto
    JOURNAL OF DAIRY SCIENCE, 2024, 107 (07) : 5122 - 5131
  • [23] DIAGNOSIS OF OVARIAN ACYCLICITY IN LACTATING DAIRY-COWS AND EVALUATION OF TREATMENT WITH GONADOTROPIN-RELEASING HORMONE OR A PROGESTERONE-RELEASING INTRAVAGINAL DEVICE
    BALL, PJH
    LAMMING, GE
    BRITISH VETERINARY JOURNAL, 1983, 139 (06): : 522 - 527
  • [24] Is the effect of premature elevated progesterone augmented by human chorionic gonadotropin versus gonadotropin-releasing hormone agonist trigger?
    Connell, Matthew T.
    Patounakis, George
    Healy, Mae Wu
    DeCherney, Alan H.
    Devine, Kate
    Widra, Eric
    Levy, Michael J.
    Hill, Micah J.
    FERTILITY AND STERILITY, 2016, 106 (03) : 584 - +
  • [25] Dual trigger with gonadotropin-releasing hormone and human chorionic gonadotropin for poor responders
    Eser, Ahmet
    Devranoglu, Belgin
    Ergen, Evrim Bostanci
    Abide, Cigdem Yayla
    JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, 2018, 19 (02) : 98 - 103
  • [26] Relationship Between Gonadotropin-Releasing Hormone/Gonadotropin-Releasing Hormone Receptor Signaling and Progesterone Receptors in Human Trophoblasts
    Lee, Bang Hyun
    Kim, Jae Hoon
    Park, Tae Chul
    Lee, Hee Joong
    JOURNAL OF REPRODUCTIVE MEDICINE, 2016, 61 (5-6) : 275 - 281
  • [27] ECONOMIC MODELING OF THE USE OF GONADOTROPIN-RELEASING HORMONE AT INSEMINATION TO IMPROVE FERTILITY IN DAIRY-COWS
    WEAVER, LD
    DALEY, CA
    GOODGER, WJ
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1988, 192 (12): : 1714 - 1719
  • [28] Gonadotropin-releasing hormone/human chorionic gonadotropin β based recombinant antibodies and vaccines
    Talwar, G. P.
    Vyas, Hemant K.
    Purswani, Shilpi
    Gupta, Jagdish C.
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2009, 83 (1-2) : 158 - 163
  • [29] EFFECTS OF ESTROGENS AND CHORIONIC-GONADOTROPIN ON HYPOPHYSEAL RESPONSE TO GONADOTROPIN-RELEASING HORMONE
    POLLERI, A
    ROLANDI, E
    CAPITANIO, GL
    VENTURINI, PL
    INDIVERI, F
    BARABINO, A
    BOLLETTINO DELLA SOCIETA ITALIANA DI BIOLOGIA SPERIMENTALE, 1973, 49 (20): : 1180 - 1185
  • [30] Gonadotropin-Releasing Hormone Agonist Use to Guide Diagnosis and Treatment of Autoimmune Progesterone Dermatitis
    Domeyer-Klenske, Amy
    Robillard, Diana
    Pulvino, John
    Spratt, Daniel
    OBSTETRICS AND GYNECOLOGY, 2015, 125 (05): : 1114 - 1116